CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
Clinical trial NCT03292809 · COMPLETED
Trial details
- NCT number
- NCT03292809
- Sponsor
- Novaliq GmbH
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-19
- Primary completion
- 2018-05-22
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.